Abstract Body

Background

The rectal mucosa, a major portal for HIV-1 entry, harbors a microbial community that shapes local immune homeostasis and might influence systemic immune responses to vaccines. We investigated the bidirectional interactions between the rectal microbiome and vaccine-induced binding antibody (bAb) responses in the RV144 ALVAC-HIV / AIDSVAX® B/E prime/boost vaccine regimen given in the RV306 trial.

Methods

Rectal mucosal samples were collected from male participants in the RV306 trial at baseline (n=44), two weeks post 1st (n=45) and two weeks post 2nd ALVAC-HIV / AIDSVAX® B/E boost (n=41). Participants were classified as high or low responders based on tertile distributions of all available bAb responses (including plasma and mucosa IgG and IgA) after the 2nd ALVAC-HIV / AIDSVAX® B/E boost (peak immunogenicity). Rectal microbiota was profiled with shotgun metagenomics using MetaPhlAn3 and differential abundance analysis was conducted using MaAsLin2 and Linear Mixed Models, adjusting for collection site (Bangkok and Chiang Mai). Correlations with complete blood count parameters were also assessed.

Results

A consistent pattern of discriminant core bacteria distinguished high and low responders at peak immunogenicity across four classes of plasma IgG, which have been previously associated to lower acquisition risk: IgG gp70 V1V2 CaseA2, IgG gp70 V1V2 92TH023, IgG gp120 MNgD- D11 and IgG1 gp120 A244gD- D11. Bacteroides and Blautia spp. were enriched in high responders, while Eubacterium and Dorea spp. were depleted. Furthermore, Ruminococcus gnavus was consistently more abundant in high responders, after 1st and 2nd ALVAC-HIV / AIDSVAX® B/E boost, while R. torques was reduced in high responders after vaccinations. The majority of enriched bacteria in high responders positively correlated with neutrophil percentage at baseline and peak immunogenicity, while depleted bacteria were negatively associated. In contrast, the opposite trend was observed for lymphocyte percentage.

Conclusions

Observed differences in bacterial taxa between plasma IgG high and low responders, and their contrasting associations with neutrophil and lymphocyte frequencies, suggest a dynamic interaction between the rectal mucosal microbiota and systemic host humoral responses to a preventive HIV vaccine, likely through distinct inflammatory signaling pathways.